...
首页> 外文期刊>Cardiovascular Research >The future application of induced pluripotent stem cells in vascular regenerative medicine
【24h】

The future application of induced pluripotent stem cells in vascular regenerative medicine

机译:诱导多能干细胞在血管再生医学中的未来应用

获取原文
获取原文并翻译 | 示例

摘要

The transplantation of autologous stem cells is the gold standard for regenerative therapy, which includes both local transplantation of the cells to injured organs and the engineering of organs. The use of smooth muscle cells (SMCs) has been shown to improve cardiac, vascular, and respiratory function. SMCs in the vasculature mimic natural healing mechanisms. The important cells for vascular regenerative medicine are mesenchymal stromal cells. The sources of mesenchy-mal stem cells (MSCs) are well defined and include bone marrow, fat, amniotic fluid, umbilical cord, muscle-derived stem cells, and hair follicle-derived MSCs.
机译:自体干细胞的移植是再生治疗的金标准,这包括将细胞局部移植到受损器官和器官工程。已显示使用平滑肌细胞(SMC)可改善心脏,血管和呼吸功能。脉管系统中的SMC模仿自然愈合机制。用于血管再生医学的重要细胞是间充质基质细胞。间充质干细胞(MSC)的来源已明确定义,包括骨髓,脂肪,羊水,脐带,肌肉来源的干细胞和毛囊来源的MSC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号